A detailed history of Private Trust CO Na transactions in Exact Sciences Corp stock. As of the latest transaction made, Private Trust CO Na holds 26 shares of EXAS stock, worth $1,799. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 26 -0.0%
Holding current value
$1,799
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$56.27 - $73.77 $14,067 - $18,442
-250 Reduced 90.58%
26 $1,000
Q4 2023

Jan 24, 2024

SELL
$59.06 - $75.72 $11,930 - $15,295
-202 Reduced 42.26%
276 $20,000
Q3 2023

Oct 18, 2023

SELL
$65.94 - $99.04 $131 - $198
-2 Reduced 0.42%
478 $32,000
Q2 2023

Jul 28, 2023

BUY
$62.68 - $95.05 $30,086 - $45,624
480 New
480 $45,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.